The Holistic Reports “Coronavirus (COVID 19) Vaccine Pipeline Assessment 2020

The Holistic Reports “Coronavirus (COVID 19) Vaccine Pipeline Assessment 2020” provides a comprehensive analysis of the fast-evolving, high-growth global Coronavirus (COVID 19) vaccine market. The report offers the most up-to-date industry data on the actual market situation for the Coronavirus (COVID 19) vaccine.

 

The report explores a detailed analysis of the introduction of the coronavirus, pathogen characteristics, signs and symptoms, transmission, and prevention. It also evaluates the vaccines developed against MERS-CoV and SARS-CoV. The report reviews a clear insight into the funding of the Coronavirus (COVID-19) vaccine research. The report also offers comprehensive information about the recruiting clinical trials statement by phase, trial status, study sponsor name, and study phase. The report investigates detailed insights about countries, territories, or areas with reported laboratory-confirmed Coronavirus (COVID-19) cases and deaths. Key trends in terms of collaboration and partnership deals are analyzed with details.

The report concludes with the profiles of the key vaccine developers in the global coronavirus vaccine market. The key players are evaluated on the various parameters such as business overview, promising vaccine in clinical development, and recent development.

To download free sample of report Click on: http://www.theholisticreports.com/request-sample/706

To Buy the report Click on: http://www.theholisticreports.com/checkout/sales/5007

(After the payment confirmation the report will be dispatched ASAP on your registered email address)

To know the offers or to know more free benefits contacts us on: help@theholisticreports.com or call on

+1 406 924 9271

To know the lowest cost of the report Click on: http://www.theholisticreports.com/Coronavirus-COVID-19-Vaccine-Pipeline-Assessment-2020-market 

Report Scope:

• Extensive coverage of the Coronavirus (COVID-19) vaccine under development
• Detailed Insights of the Introduction, Pathogen Characteristics, Signs and Symptoms, Transmission and Prevention
• Provides Comprehensive Insights on the Funding of the Coronavirus (COVID-19) Vaccine Research
• Thoroughly Evaluates Vaccines Developed Against MERS-CoV and SARS-CoV
• Reviews Most Recent Clinical Trials of the Coronavirus Vaccines
• Scrutinizes Countries, Territories or Areas with Reported Laboratory-Confirmed Coronavirus (COVID-19) Cases and Deaths
• Provides Key Trends with Respect to Collaboration and Partnership Deals
• An Insightful Analysis of the Key Vaccine Developers Along with the Analysis of their Promising Vaccines in the Clinical Development, Phase, Platform Technology, and Recent Development

Key Vaccine Developers Covered in the Report

• University of Oxford
• Clover Biopharmaceuticals/Dynavax/GlaxoSmithKline
• Heat Biologics Inc./University of Miami
• Inovio Pharmaceuticals Inc
• Janssen Pharmaceutical
• Sanofi Pasteur/GlaxoSmithKline (GSK)
• Moderna/NIAID
• Novavax
• Sanofi Pasteur/Translate Bio Inc.
• Vaxart Inc.
• Altimmune
• Medicago
• BioNTech/Pfizer/Fosun Pharma
• GeoVax/BravoVax
• Arcturus Therapeutics/Duke-NUS
• CanSino Biological Inc/Beijing Institute of Biotechnology
• Takis Biotech/Applied DNA Sciences/Evvivax
• Cobra Biologics/Karolinska Institute
• Zydus Cadila
• Codagenix/Serum Institute of India
• Greffex
• ExpreS2ion Biotechnologies ApS
• Vaxil Bio Therapeutics
• Flow Pharma Inc
• AJ Vaccines
• Generex Biotechnology/EpiVax
• Immunomic Therapeutics/EpiVax/PharmaJet
• iBio Inc/CC-Pharming Ltd/Infectious Disease Research Institute
• VIDO-InterVac/University of Saskatchewan/International Vaccine Institute
• Tonix Pharmaceuticals/Southern Research
• IAVI/Batavia Biosciences
• Curevac
• Imophoron Ltd/University of Bristol
• BioNet Asia
• Sinovac/Dynavax
• BIOCAD
• University of Pittsburgh

 

Table Of Content:

1. Executive Summary

 

1. Coronavirus (COVID-19) - Introduction, Pathogen Characteristics, Signs and Symptoms, Transmission and Prevention

2.1 Introduction

2.2 Pathogen Characteristics

2.3 Signs and Symptoms

2.4 Transmission

2.5 Prevention

1. Funding in the Coronavirus (COVID-19) Vaccine Research
2. Vaccines Developed Against MERS-CoV
3. Vaccines Developed Against SARS-CoV
4. Coronavirus (COVID-19) Vaccine Clinical Trial Insights by Phase, Company and Country
5. Countries, Territories or Areas with Reported Laboratory-Confirmed Coronavirus (COVID-19) Cases and Deaths
6. Major Partnership and Collaboration Deals in the Coronavirus (COVID – 19) Vaccine Market

8.1 Collaboration Deals

8.2 Partnership Deals

1. Key Vaccine Developers Analysis

9.1 University of Oxford

9.1.1 Business Overview

9.1.2 Promising Coronavirus Vaccines in the Clinical Development

9.1.3 Recent Development

9.2 Clover Biopharmaceuticals/Dynavax/GlaxoSmithKline

9.2.1 Business Overview

9.2.2 Promising Coronavirus Vaccines in the Clinical Development

9.2.3 Recent Development

9.3 Heat Biologics Inc./University of Miami

9.3.1 Business Overview

9.3.2 Promising Coronavirus Vaccines in the Clinical Development

9.3.3 Recent Development

9.4 Inovio Pharmaceuticals Inc

9.4.1 Business Overview

9.4.2 Promising Coronavirus Vaccines in the Clinical Development

9.4.3 Recent Development

9.5 Janssen Pharmaceutical

9.5.1 Business Overview

9.5.2 Promising Coronavirus Vaccines in the Clinical Development

9.5.3 Recent Development

9.6 Sanofi Pasteur/GlaxoSmithKline (GSK)

9.6.1 Business Overview

9.6.2 Promising Coronavirus Vaccines in the Clinical Development

9.6.3 Recent Development

9.7 Moderna/NIAID

9.7.1 Business Overview

9.7.2 Promising Coronavirus Vaccines in the Clinical Development

9.7.3 Recent Development

9.8 Novavax

9.8.1 Business Overview

9.8.2 Promising Coronavirus Vaccines in the Clinical Development

9.8.3 Recent Development

9.9 Sanofi Pasteur/Translate Bio Inc.

9.9.1 Business Overview

9.9.2 Promising Coronavirus Vaccines in the Clinical Development

9.9.3 Recent Development

9.10 Vaxart Inc.

9.10.1 Business Overview

9.10.2 Promising Coronavirus Vaccines in the Clinical Development

9.10.3 Recent Development

9.11 Altimmune

9.11.1 Business Overview

9.11.2 Promising Coronavirus Vaccines in the Clinical Development

9.11.3 Recent Development

9.12 Medicago

9.12.1 Business Overview

9.12.2 Promising Coronavirus Vaccines in the Clinical Development

9.12.3 Recent Development

9.13 BioNTech/Pfizer/Fosun Pharma

9.13.1 Business Overview

9.13.2 Promising Coronavirus Vaccines in the Clinical Development

9.13.3 Recent Development

9.14 GeoVax/BravoVax

9.14.1 Business Overview

9.14.2 Promising Coronavirus Vaccines in the Clinical Development

9.14.3 Recent Development

9.15 Arcturus Therapeutics/Duke-NUS

9.15.1 Business Overview

9.15.2 Promising Coronavirus Vaccines in the Clinical Development

9.15.3 Recent Development

9.16 CanSino Biological Inc/Beijing Institute of Biotechnology

9.16.1 Business Overview

9.16.2 Promising Coronavirus Vaccines in the Clinical Development

9.16.3 Recent Development

9.17 Takis Biotech/Applied DNA Sciences/Evvivax

9.17.1 Business Overview

9.17.2 Promising Coronavirus Vaccines in the Clinical Development

9.17.3 Recent Development

9.18 Cobra Biologics/Karolinska Institute

9.18.1 Business Overview

9.18.2 Promising Coronavirus Vaccines in the Clinical Development

9.18.3 Recent Development

9.19 Zydus Cadila

9.19.1 Business Overview

9.19.2 Promising Coronavirus Vaccines in the Clinical Development

9.19.3 Recent Development

9.20 Codagenix/Serum Institute of India

9.20.1 Business Overview

9.20.2 Promising Coronavirus Vaccines in the Clinical Development

9.20.3 Recent Development

9.21 Greffex

9.21.1 Business Overview

9.21.2 Promising Coronavirus Vaccines in the Clinical Development

9.21.3 Recent Development

9.22 ExpreS2ion Biotechnologies ApS

9.22.1 Business Overview

9.22.2 Promising Coronavirus Vaccines in the Clinical Development

9.22.3 Recent Development

9.23 Vaxil Bio Therapeutics

9.23.1 Business Overview

9.23.2 Promising Coronavirus Vaccines in the Clinical Development

9.23.3 Recent Development

9.24 Flow Pharma Inc

9.24.1 Business Overview

9.24.2 Promising Coronavirus Vaccines in the Clinical Development

9.24.3 Recent Development

9.25 AJ Vaccines

9.25.1 Business Overview

9.25.2 Promising Coronavirus Vaccines in the Clinical Development

9.25.3 Recent Development

9.26 Generex Biotechnology/EpiVax

9.26.1 Business Overview

9.26.2 Promising Coronavirus Vaccines in the Clinical Development

9.26.3 Recent Development

9.27 Immunomic Therapeutics/EpiVax/PharmaJet

9.27.1 Business Overview

9.27.2 Promising Coronavirus Vaccines in the Clinical Development

9.27.3 Recent Development

9.28 iBio Inc/CC-Pharming Ltd/Infectious Disease Research Institute

9.28.1 Business Overview

9.28.2 Promising Coronavirus Vaccines in the Clinical Development

9.28.3 Recent Development

9.29 VIDO-InterVac/University of Saskatchewan/International Vaccine Institute

9.29.1 Business Overview

9.29.2 Promising Coronavirus Vaccines in the Clinical Development

9.29.3 Recent Development

9.30 Tonix Pharmaceuticals/Southern Research

9.30.1 Business Overview

9.30.2 Promising Coronavirus Vaccines in the Clinical Development

9.30.3 Recent Development

9.31 IAVI/Batavia Biosciences

9.31.1 Business Overview

9.31.2 Promising Coronavirus Vaccines in the Clinical Development

9.31.3 Recent Development

9.32 Curevac

9.32.1 Business Overview

9.32.2 Promising Coronavirus Vaccines in the Clinical Development

9.32.3 Recent Development

9.33 Imophoron Ltd/University of Bristol

9.33.1 Business Overview

9.33.2 Promising Coronavirus Vaccines in the Clinical Development

9.33.3 Recent Development

9.34 BioNet Asia

9.34.1 Business Overview

9.34.2 Promising Coronavirus Vaccines in the Clinical Development

9.34.3 Recent Development

9.35 Sinovac/Dynavax

9.35.1 Business Overview

9.35.2 Promising Coronavirus Vaccines in the Clinical Development

9.35.3 Recent Development

9.36 BIOCAD

9.36.1 Business Overview

9.36.2 Promising Coronavirus Vaccines in the Clinical Development

9.36.3 Recent Development

9.37 University of Pittsburgh

9.37.1 Business Overview

9.37.2 Promising Coronavirus Vaccines in the Clinical Development

9.37.3 Recent Development

To download free sample of report Click on: http://www.theholisticreports.com/request-sample/706

To Buy the report Click on: http://www.theholisticreports.com/checkout/sales/5007

(After the payment confirmation the report will be dispatched ASAP on your registered email address)

To know the offers or to know more free benefits contacts us on: help@theholisticreports.com or call on

+1 406 924 9271

To know the lowest cost of the report Click on: http://www.theholisticreports.com/Coronavirus-COVID-19-Vaccine-Pipeline-Assessment-2020-market 

 

Similar Reports Available from the Industry for a bundle purchase with 50% discount:

1) World Medical Composites Market by Fiber Type view and Forecast, 2018-2025 

Link: http://www.theholisticreports.com/report/53/world-medical-composites-market-by-fiber-type-market-overview-and-forecast-2018-2025

2)  World Artificial Intelligence for Drug Discovery and Development Market by Drug Type (Large Molecules and Small Molecules ), Technology Type (Deep Learning and Machine Learning), Application (Cardiovascular Disease, Oncology, Metabolic Disease, Neurodegenerative Disease, and Others), and End User ( Pharmaceutical & Biopharmaceutical Companies and Research Institutes): Opportunity Analysis and Industry Forecast, 2018 - 2026 . 

Link:  http://www.theholisticreports.com/report/140/world-artificial-intelligence-for-drug-discovery-and-development-market

3)  Global Medical Display Market 2020-2026 by Technology, Platform Type, Resolution, Display Color, Panel Size, Application, and Region: Trend Forecast and Growth Opportunity

Link: http://www.theholisticreports.com/report/143/Global-Medical-Display-Market-2020-2026-by-Technology-Platform-Type-Resolution-Display-Color-Panel-Size-Application-and-RegionTrend-Forecast-and-Growth-Opportunity

Contact Us: help@theholisticreports.com  ( The report can be also customized as per your niche requiremnets in a cost effective manner, we also provide a free COVID-19 Business Recovering Strategy Plan worth USD 1200 with our each report upon your request) 

Welcome to the World of Economical and Quality Research Center